Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Phreesia Inc (NY: PHR )

20.36 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Phreesia Inc

< Previous 1 2 3 4 5 6 7 8 Next >
Phreesia’s Hilary Hatch Named a “Disrupter” in PM360’s ELITE 100
From Phreesia
Via Business Wire
Phreesia Sets Release Date for Fiscal First Quarter 2024 Results
From Phreesia, Inc.
Via Business Wire
Elliott Wave Technical Analysis: Phreesia Inc. - Thursday, April 20
Looking for upside to first break the base of the ending diagonal as additional confirmation. 
Via Talk Markets
9 Analysts Have This to Say About Phreesia
Via Benzinga
Phreesia's Earnings: A Preview
Via Benzinga
Analyst Expectations for Phreesia's Future
Via Benzinga
Elliott Wave Technical Analysis: Phreesia Inc.
Looking for a clear five wave move to then look for longs. 
Via Talk Markets
Analyst Expectations for Phreesia's Future
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Via Benzinga
Unlimited Systems Partners with Phreesia, Improving Efficiency and Offering an Integrated Patient-Driven Intake Experience for Oncology Groups
From Phreesia
Via Business Wire
Analyst Ratings for Phreesia
Via Benzinga
Where Phreesia Stands With Analysts
Via Benzinga
Phreesia Gets Price Target Bumps By Analysts Following Q4 Results
Phreesia, Inc. (NYSE: PHR) reported results for its fourth quarter. Phreesia posted a quarterly loss of $0.72 per share, versus analysts’ expectations for a loss of $0.51 per share. The company’s... 
Via Benzinga
89bio To Rally 265%? Here Are 10 Other Analyst Forecasts For Thursday
Baird cut the price target for Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) from $14 to $11. Baird analyst Justin Kleber maintained an Outperform rating. Petco Health and Wellness shares rose... 
Via Benzinga
Phreesia Announces Chief Financial Officer Transition
From Phreesia, Inc.
Via Business Wire
Phreesia Announces Fourth Quarter Fiscal 2023 Results
From Phreesia, Inc.
Via Business Wire
Phreesia Named as One of the Achievers 50 Most Engaged Workplaces® of 2023
From Phreesia
Via Business Wire
Phreesia’s Alexandra Beneville Named One of MM+M’s ‘Women to Watch’ for 2023
From Phreesia
Via Business Wire
Phreesia’s Dan Nathan Named as a Top Software CTO of 2023
From Phreesia
Via Business Wire
Elliott Wave Technical Analysis: Phreesia Inc. - Wednesday, March 15
Looking for a break of wave (b) to have further confirmation. 
Via Talk Markets
Phreesia Sets Release Date for Fiscal Fourth Quarter 2023 Results
From Phreesia, Inc.
Via Business Wire
Phreesia Included in 2023 Bloomberg Gender-Equality Index for the Third Consecutive Year
From Phreesia
Via Business Wire
Phreesia and the Ad Council Partnership Drives Strong Engagement Across 3 Public Health Campaigns
From Phreesia
Via Business Wire
Phreesia Life Sciences Named One of MM+M’s “Best Places to Work 2022”
From Phreesia Life Sciences
Via Business Wire
What Does Amazon's Acquisition of 1LifeMedical Mean To Investors?
After the announcement in July, the Amazon acquisition of One Medical is complete. What does this deal mean for healthcare or tech investors? 
Via MarketBeat
Topics Initial Public Offering Regulatory Compliance
Exposures Legal Regulatory Securities Market
Needham Remains Bullish On Phreesia & Udemy; Adds Both To Conviction List
Via Benzinga
Netflix To Rally Around 29%? Here Are 10 Other Price Target Changes For Friday
Wells Fargo raised Netflix, Inc. (NASDAQ: NFLX) price target from $300 to $400. Wells Fargo also upgraded the stock from Equal Weight to Overweight. Netflix shares rose 0.6% to close at $310.26 on... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
Via Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
Phreesia Announces Third Quarter Fiscal 2023 Results
From Phreesia, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS